Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

32.45
Delayed Data
As of Feb 12
 +1.26 / +4.04%
Today’s Change
27.78
Today|||52-Week Range
80.71
-59.12%
Year-to-Date

Today’s Trading

Previous close31.19
Today’s open31.37
Day’s range30.53 - 32.65
Volume2,303,294
Average volume (3 months)1,330,700
Market cap$4.9B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-229.95%
Earnings growth (this year)-212.28%
Earnings growth (next 5 years)+51.60%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales13.75
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+1.86+6.51%
OPKOPKO Health Inc-0.11-1.38%
TAROTaro Pharmaceutical ...+1.87+1.42%
SGENSeattle Genetics Inc+1.60+5.92%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$618.8M
Annual profit (last year)-$30.1M
Net profit margin-4.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers